Dermatology Update: The New, The Old, The Common and The Rare
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Dermatology Update: The New, The Old, The Common and The Rare
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Join the Derms on Drugs as we slice and dice the latest dermatology literature. We've got stuff that will change what you do next week, answers for uncommon but challenging diseases and the latest updates on the pharma pipeline. We'll answer burning questions, like:
-When is the best time to start niacinamide for skin cancer prevention?
-Which drugs work the best for the itch of atopic dermatitis and prurigo nodularis?
-Is minoxidil 5 mg actually better than minoxidil 2.5 mg?
-What can do when for PLEVA that's not responding to the usual treatments?
-Is icotrokinra (the new oral IL-23 inhibitor) more effective than Sotyktu?
-What can you do for patients with skin involvement of systemic mastocytosis?
-Are there patients who really have both atopic dermatitis AND psoriasis?
-Opzelura just got approved down to age 2 - how well does it work in that age range?